This post was originally published on this site
By Cecilia Butini
Roche Holding AG on Wednesday posted a decline in sales for the first quarter as its diagnostics division suffered from significantly lower demand for Covid-19 tests, and backed its outlook for the year.
The Swiss pharma major reported sales of 15.32 billion euros ($16.82 billion) for the first quarter, down from CHF16.45…
